Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Vanderbilt-Ingram Cancer Center
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Allogeneic hematopoietic stem cell transplant recipients who are \>6 post-transplant
greater than or equal to 18 years of age
Available for duration of study
If patients are on immunosuppressive therapy for treatment of graft versus host disease (GVHD): only those on stable doses for at least 4 weeks or on tapering doses will be eligible.
You may not be if
History of hypersensitivity to previous influenza vaccination or hypersensitivity to eggs/egg protein
History of Guillain-Barre syndrome
Evidence of hematologic malignancy or disease relapse post-transplant (mixed chimerisms and molecular evidence of disease is permitted)
History of receiving 2011 - 2012 influenza vaccine
History of proven influenza disease after September 1, 2011.
Pregnant females
Have any condition that would, in the opinion of the site investigator, place them at an unacceptable risk of injury or render them unable to meet the requirements of the protocol
Have any condition that the investigator believes may interfere with successful completion of the study
Platelet count less than 50,000 cells/μL
History of known infection with HIV, Hepatitis B or Hepatitis C
